Search results
'An Officer and a Gentleman' actor Louis Gossett Jr. died from COPD, report says: What to know about...
Yahoo Canada Style· 21 hours agoThis article is for informational purposes only and is not a substitute for professional medical...
Earnings call: Amgen reports robust Q1 2024 sales and pipeline progress By Investing.com
Investing.com· 2 hours agoThe biotechnology company has seen a 22% increase in sales, driven by key products such as Repatha,...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript May 2, 2024 Regeneron...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 4 days agoKey opinion leaders (KOLs) interviewed by GlobalData have expressed mixed opinions about Fasenra,...
Pulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 hours agoPulmonx Corporation (NASDAQ:LUNG) Q1 2024 Earnings Call Transcript May 1, 2024 Pulmonx Corporation...
Regeneron Reverses On Better-Than-Feared Eylea Sales As Patent Expiration Looms
Investor's Business Daily· 21 hours agoRegeneron stock is forming a flat base with a buy point at 998.33, according to MarketSurge. That's...
Mesothelioma
Health· 5 hours agoRelated conditions include: Chronic obstructive pulmonary disease (COPD): Affects your breathing ability and blocks airflow Coronary artery disease...
Regeneron Pharmaceuticals Inc (REGN) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 10 hours agoRegeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi's sBLA for Dupixent for COPD treatment was accepted by the FDA for priority review, highlighting ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 hours agoThe company is working on a drug to treat liver fibrosis due to hepatitis B and metabolic...
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
WFRV 5 Green Bay· 2 days agoSociety (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look forward to presenting encouraging data from our Phase 2a COURSE trial in COPD with ...
